Nature Biotechnology 2006 Jim Kling - Abstracts
| Nature Biotechnology 2006 Jim Kling | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Amgen becomes a strong cancer player.(acquisition of Abgenix Inc.) | Business | Jim Kling | |||
| Bundling next-generation cancer therapies for synergy. | Business | Jim Kling | |||
| China offers alternative gateways for experimental drugs. | Business | Jim Kling, Hepeng Jia | |||
| Merck moves into biotech.(Merck & Company Inc) | Business | Jim Kling | |||
| Moving diagnostics from the bench to the bedside. | Business | Jim Kling | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.